Related Experiment Video
Updated: Jul 15, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic
Luciano Potena1, Rossella Ferrara, Edward S Mocarski
1Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Bologna. luciano.potena2@unibo.it
Cardiac allograft vasculopathy is still the main cause of long-term graft loss after heart transplantation. Indeed, recent advances in immunosuppression management led to a significant improvement in short-term survival, while long-term death rate did not change significantly in the last 20 years. In this paper, we will review the latest advances in the understanding of this peculiar form of atherosclerosis, focusing on the mechanisms that can be potentially targeted by specific therapeutic interventions.
Cardiac allograft vasculopathy is still the main cause of long-term graft loss after heart transplantation. Indeed, recent advances in immunosuppression management led to a significant improvement in short-term survival, while long-term death rate did not change significantly in the last 20 years. In this paper, we will review the latest advances in the understanding of this peculiar form of atherosclerosis, focusing on the mechanisms that can be potentially targeted by specific therapeutic interventions.
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Cell-mediated Immune Responses
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Type I Diabetes II: Pathophysiology
